The phosphatidylinositol 3-kinase/akt signaling pathway in medullary thyroid cancer
- 4 September 2008
- journal article
- review article
- Published by Elsevier BV in Surgery
- Vol. 144 (5), 721-724
- https://doi.org/10.1016/j.surg.2008.06.028
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cellsMolecular Cancer Therapeutics, 2007
- Overexpression of the NOTCH1 Intracellular Domain Inhibits Cell Proliferation and Alters the Neuroendocrine Phenotype of Medullary Thyroid Cancer CellsPublished by Elsevier BV ,2006
- Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002Surgery, 2006
- In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancerAnti-Cancer Drugs, 2006
- Role of MEN2A-Derived RET in Maintenance and Proliferation of Medullary Thyroid CarcinomaJNCI Journal of the National Cancer Institute, 2004
- Antiproliferative Effects of Src Inhibition on Medullary Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2004
- The role of human achaete-scute homolog-1 in medullary thyroid cancer cellsSurgery, 2003
- Targeting the PI3K-Akt pathway in human cancerCancer Cell, 2003
- Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.2001
- Transforming Ability of MEN2A-RET Requires Activation of the Phosphatidylinositol 3-Kinase/AKT Signaling PathwayPublished by Elsevier BV ,2000